fashion -WSS

fashion

author：focus 2025-09-06 04:37:00 - browse：6947

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Childhood vaccination ad campaign launches in the U.K.

hotspot

WSS

Ohio train derailment: Experts on toxic chemical risks

Marc Tessier

Redefining sustainability for the pharmaceutical industry

Childhood vaccination ad campaign launches in the U.K.

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Wikipedia

fashion

focus

Apple is now the first public company to be valued at $3 trillion

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Jerome Adams on the need for new antivirals for Covid

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Heart attack and stroke risk calculators need revising

CDC: Cases of alpha

Dobbs anniversary: the lost opportunity of abortion as health care

Interest rates are at a 22

After affirmative action ruling, medical educators look to 'holistic review'

Redefining sustainability for the pharmaceutical industry

entertainment

Ford recalls 870K F

Ford recalls 870K F

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Cholera vaccine supplies dangerously low, outbreaks surging

Redefining sustainability for the pharmaceutical industry

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

focus

focus

hotspot

entertainment